US Revokes Visas Of Some Indian Executives, Their Families, Over Drug Trafficking Allegations | World News

New Delhi: The US Embassy in the new Delhi said on Thursday that he has canceled and rejected visas for some Indian business managers and corporate leaders accused of joining the smuggling of Fentanil pioneering chemicals.

This development came shortly after publishing a warning to US President Donald Trump’s widespread drug trafficking and narcotic production. India was among the 23 countries where the US emphasized monitoring in this context.

Stopping the flow of Fentanil and its predecessors to the United States is one of our highest priorities. We canceled visas for company managers and family to illegal participation in controlled substance smuggling, including Fentanil. Those who facilitate the flow… pic.twitter.com/atwupz7wlg– US Embassy India (@usandindia) 18 September 2025

According to the Embassy, ​​visa cancellations are part of Washington’s efforts to protect Americans from the dangers of synthetic narcotics.

“As a result of this decision, these individuals and close family members are not suitable for traveling to the United States,” the US Embassy said in a press release.

The Embassy also noted that managers associated with companies known to be Fentanil pioneers who tray human trafficking will be marked during future visa applications.

Emphasizing the threat of Fentanil and illegal drug trafficking, the US Embassy was grateful to the Indian government for the cooperation of addressing the issue.

“Individuals and organizations participating in illegal production and drug trade in the United States will also encounter consequences that may include the rejection of access to the United States with their families, Jor

Earlier this year, the US, China and India described illegal pioneering chemicals as the main sources of pill -printing equipment. In March, three employees of an Indian -based chemical company allegedly imported the pioneering chemicals used in the production of fentanyl at a Washington, DC Federal Court.

The announcement of the embassy follows Trump’s previous 23 countries, including India, as “large drug transportation or major illegal drugs producing”.

“The countries where these drugs are caused and switching to, should fulfill their obligations and close these materials or face serious consequences, Tr Trump warned.

Other countries mentioned in the list include Pakistan, China, Afghanistan, Bahamalar, Belize, Bolivia, Burma, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Peru and Venezo, Nicaragua, Panama, Laos, Mexico, Nicaragua, Panama, Panama.